|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07B 59/00 | |
| A61K 31/40 | |||
| C07D 403/06 | |||
| C07D 405/10 | |||
| A61P 43/00 |
| (11) | Number of the document | 2968268 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14767862.7 |
| Date of filing the European patent application | 2014-03-07 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/021984 |
| Date | 2014-03-07 |
| (87) | Number | WO 2014/150043 |
| Date | 2014-09-25 |
| (30) | Number | Date | Country code |
| 201361788946 P | 2013-03-15 | US |
| (72) |
HARBESON, Scott L., US
|
| (73) |
Concert Pharmaceuticals Inc.,
65 Hayden Avenue, Suite 3000N, Lexington, MA 02421,
US
|
| (54) | INHIBITORS OF THE ENZYME UDP-GLUCOSE: N-ACYL-SPHINGOSINE GLUCOSYLTRANSFERASE |
| INHIBITORS OF THE ENZYME UDP-GLUCOSE: N-ACYL-SPHINGOSINE GLUCOSYLTRANSFERASE |